title: Apremilast and suicidality - a retrospective analysis of three large databases: the FAERS, EudraVigilance and a large single-centre US patient population.
authors.affiliation: Department of Dermatology, Northwestern University Feinberg School of Medicine, 676 N. Saint Clair Street, Suite 1600, Chicago, IL, 60611, USA.
authors.forename: P P
authors.initials: PP
authors.lastname: Vakharia
authors.affiliation: Department of Dermatology, Northwestern University Feinberg School of Medicine, 676 N. Saint Clair Street, Suite 1600, Chicago, IL, 60611, USA.
authors.forename: K A
authors.initials: KA
authors.lastname: Orrell
authors.affiliation: Department of Dermatology, Northwestern University Feinberg School of Medicine, 676 N. Saint Clair Street, Suite 1600, Chicago, IL, 60611, USA.
authors.forename: D
authors.initials: D
authors.lastname: Lee
authors.affiliation: Department of Dermatology, Northwestern University Feinberg School of Medicine, 676 N. Saint Clair Street, Suite 1600, Chicago, IL, 60611, USA.
authors.forename: S M
authors.initials: SM
authors.lastname: Rangel
authors.affiliation: Department of Dermatology, Northwestern University Feinberg School of Medicine, 676 N. Saint Clair Street, Suite 1600, Chicago, IL, 60611, USA.
authors.forename: E
authors.initials: E
authors.lastname: Lund
authors.affiliation: Department of Dermatology, Northwestern University Feinberg School of Medicine, 676 N. Saint Clair Street, Suite 1600, Chicago, IL, 60611, USA.
authors.forename: A E
authors.initials: AE
authors.lastname: Laumann
authors.affiliation: Department of Dermatology, Northwestern University Feinberg School of Medicine, 676 N. Saint Clair Street, Suite 1600, Chicago, IL, 60611, USA.
authors.forename: D P
authors.initials: DP
authors.lastname: West
authors.affiliation: Department of Dermatology, Northwestern University Feinberg School of Medicine, 676 N. Saint Clair Street, Suite 1600, Chicago, IL, 60611, USA.
authors.forename: B
authors.initials: B
authors.lastname: Nardone
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D006801:Humans; D060735:Pharmacovigilance; D011358:Product Surveillance, Postmarketing; D011565:Psoriasis / Q000188:drug therapy*; D012189:Retrospective Studies; D012307:Risk Factors; D013405:Suicide / Q000706:statistics & numerical data*; D013792:Thalidomide / Q000009:adverse effects / Q000031:analogs & derivatives*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D013792:Thalidomide; C505730:apremilast